Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Venlafaxine - Pfizer

Next Previous
X
Search
Drug Profile

Venlafaxine - Pfizer

Alternative Names: Dobupal; Efexor XR; Effexor; Effexor XR; Elafax; WY 45030; WY 45651; WY 45655

Latest Information Update: 05 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Wyeth
  • Developer Pfizer
  • Class Antidepressants; Anxiolytics; Cyclohexanols; Dimethylamines; Small molecules
  • Mechanism of Action Adrenergic uptake inhibitors; Serotonin uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Generalised anxiety disorder; Major depressive disorder; Panic disorder; Social phobia

Most Recent Events

  • 01 Apr 2022 Sumitomo Dainippon Pharma is now called Sumitomo Pharma
  • 01 Mar 2018 Pfizer and Sumitomo Dainippon Pharma agree to co-promote Venlafaxine for Major depressive disorder in Japan (PO,capsules)
  • 01 Jul 2016 Pfizer completes a phase I trial in Healthy volunteers in USA (NCT02637193)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top